Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SPTLC1 anticorps (AA 37-310)

SPTLC1 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7168895
  • Antigène Voir toutes SPTLC1 Anticorps
    SPTLC1 (serine Palmitoyltransferase, Long Chain Base Subunit 1 (SPTLC1))
    Épitope
    • 15
    • 7
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 37-310
    Reactivité
    • 54
    • 20
    • 6
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 54
    • 1
    Lapin
    Clonalité
    • 54
    • 1
    Polyclonal
    Conjugué
    • 24
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SPTLC1 est non-conjugé
    Application
    • 48
    • 20
    • 13
    • 13
    • 8
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain
    Purification
    Antigen Affinity Purified
    Immunogène
    Recombinant Human Serine palmitoyltransferase 1 protein (37-310AA)
    Isotype
    IgG
    Top Product
    Discover our top product SPTLC1 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    SPTLC1 (serine Palmitoyltransferase, Long Chain Base Subunit 1 (SPTLC1))
    Autre désignation
    SPTLC1 (SPTLC1 Produits)
    Synonymes
    anticorps ATSPT1, anticorps SERINE PALMITOYLTRANSFERASE 1, anticorps serine palmitoyltransferase 1, anticorps Afu6g00300, anticorps HSAN1, anticorps HSN1, anticorps LBC1, anticorps LCB1, anticorps SPT1, anticorps SPTI, anticorps wu:fc75h04, anticorps wu:fp41c08, anticorps zgc:112247, anticorps AW552086, anticorps C77762, anticorps E030036H05, anticorps Lcb1, anticorps RGD1306617, anticorps Spt1, anticorps serine palmitoyltransferase 1, anticorps Serine palmitoyltransferase 1, anticorps serine palmitoyltransferase long chain base subunit 1, anticorps serine palmitoyltransferase, long chain base subunit 1, anticorps serine palmitoyltransferase, long chain base subunit 1 L homeolog, anticorps SPT1, anticorps AFUA_6G00300, anticorps PAS_FragB_0040, anticorps SPTLC1, anticorps sptlc1, anticorps sptlc1.L, anticorps Sptlc1
    Sujet

    Background: Serine palmitoyltransferase (SPT). The heterodimer formed with SPTLC2 or SPTLC3 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA. The SPTLC1-SPTLC2-SPTSSB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SPTSSB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference.

    Aliases: HSAN antibody, HSAN1 antibody, HSN1 antibody, LBC1 antibody, LCB 1 antibody, LCB1 antibody, Long chain base biosynthesis protein 1 antibody, MGC14645 antibody, Serine C palmitoyltransferase antibody, Serine palmitoyl CoA transferase 1 antibody, Serine palmitoyltransferase 1 antibody, Serine palmitoyltransferase long chain base subunit 1 antibody, Serine palmitoyltransferase subunit 1 antibody, Serine-palmitoyl-CoA transferase 1 antibody, SPT 1 antibody, SPT1 antibody, SPTC1_HUMAN antibody, SPTI antibody, SPTLC 1 antibody, SPTLC1 antibody

    UniProt
    O15269
Vous êtes ici: